Trials / Completed
CompletedNCT00894556
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg for the Treatment of Acute Migraine in Sumatriptan Non-Responders
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 109 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A study to provide evidence supporting the benefit of Rizatriptan in patients who have an inadequate response to sumatriptan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rizatriptan | Single dose of 10 mg orally disintegrating tablet at onset of migraine attack |
| DRUG | Comparator: Placebo | Placebo to Rizatriptan |
| DRUG | Comparator: Sumatriptan | single dose of generic sumatriptan 100 mg at onset of migraine attack |
Timeline
- Start date
- 2009-06-10
- Primary completion
- 2010-01-12
- Completion
- 2010-01-12
- First posted
- 2009-05-07
- Last updated
- 2024-05-10
- Results posted
- 2011-01-20
Source: ClinicalTrials.gov record NCT00894556. Inclusion in this directory is not an endorsement.